Webb J, Mount J, von Arx LB, Rachman J, et al. Cardiovascular risk profiles: A cross-sectional study evaluating the generalisability of the glucagon-like peptide-1 receptor agonist cardiovascular outcome trials Rewind, Leader and Sustain-6 to the real-world type 2 diabetes population in the UK. Diabetes Obes Metab 2021 Oct 20. doi: 10.1111/dom.14580.
PMID: 34668637